Annual Shareholders Equity
-$818.55 M
-$471.47 M-135.84%
December 31, 2023
Summary
- As of February 7, 2025, PTCT annual stockholders equity is -$818.55 million, with the most recent change of -$471.47 million (-135.84%) on December 31, 2023.
- During the last 3 years, PTCT annual shareholders equity has fallen by -$1.30 billion (-269.83%).
- PTCT annual shareholders equity is now -237.73% below its all-time high of $594.33 million, reached on December 31, 2019.
Performance
PTCT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$1.05 B
-$74.17 M-7.57%
September 30, 2024
Summary
- As of February 7, 2025, PTCT quarterly stockholders equity is -$1.05 billion, with the most recent change of -$74.17 million (-7.57%) on September 30, 2024.
- Over the past year, PTCT quarterly shareholders equity has dropped by -$383.54 million (-57.18%).
- PTCT quarterly shareholders equity is now -258.87% below its all-time high of $663.65 million, reached on September 30, 2019.
Performance
PTCT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PTCT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -135.8% | -57.2% |
| 3 y3 years | -269.8% | -57.2% |
| 5 y5 years | -333.4% | -57.2% |
PTCT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | <-9999.0% | at low |
| 5 y | 5-year | -237.7% | at low | -277.4% | at low |
| alltime | all time | -237.7% | at low | -258.9% | at low |
PTC Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.05 B(+7.6%) |
| Jun 2024 | - | -$980.18 M(+9.7%) |
| Mar 2024 | - | -$893.92 M(+9.2%) |
| Dec 2023 | -$818.55 M(+135.8%) | -$818.55 M(+22.0%) |
| Sep 2023 | - | -$670.81 M(+15.8%) |
| Jun 2023 | - | -$579.27 M(+26.6%) |
| Mar 2023 | - | -$457.56 M(+31.8%) |
| Dec 2022 | -$347.09 M(<-9900.0%) | -$347.09 M(+53.0%) |
| Sep 2022 | - | -$226.90 M(+24.5%) |
| Jun 2022 | - | -$182.22 M(+101.2%) |
| Mar 2022 | - | -$90.58 M(-6399.1%) |
| Dec 2021 | $1.44 M(-99.7%) | $1.44 M(-98.6%) |
| Sep 2021 | - | $104.93 M(-46.6%) |
| Jun 2021 | - | $196.58 M(-32.8%) |
| Mar 2021 | - | $292.58 M(-39.3%) |
| Dec 2020 | $481.98 M(-18.9%) | $481.98 M(-5.7%) |
| Sep 2020 | - | $510.95 M(-10.7%) |
| Jun 2020 | - | $572.49 M(+8.3%) |
| Mar 2020 | - | $528.73 M(-11.0%) |
| Dec 2019 | $594.33 M(+69.5%) | $594.33 M(-10.4%) |
| Sep 2019 | - | $663.65 M(+35.8%) |
| Jun 2019 | - | $488.69 M(-4.7%) |
| Mar 2019 | - | $512.94 M(+46.3%) |
| Dec 2018 | $350.73 M | $350.73 M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $386.09 M(+44.4%) |
| Jun 2018 | - | $267.40 M(+77.9%) |
| Mar 2018 | - | $150.31 M(-3.9%) |
| Dec 2017 | $156.44 M(+30.8%) | $156.44 M(+7.2%) |
| Sep 2017 | - | $145.88 M(-14.1%) |
| Jun 2017 | - | $169.73 M(+68.3%) |
| Mar 2017 | - | $100.83 M(-15.7%) |
| Dec 2016 | $119.58 M(-47.1%) | $119.58 M(-14.7%) |
| Sep 2016 | - | $140.18 M(-15.4%) |
| Jun 2016 | - | $165.62 M(-15.5%) |
| Mar 2016 | - | $196.00 M(-13.3%) |
| Dec 2015 | $226.00 M(-24.3%) | $226.00 M(-16.0%) |
| Sep 2015 | - | $269.15 M(+8.3%) |
| Jun 2015 | - | $248.58 M(-9.1%) |
| Mar 2015 | - | $273.32 M(-8.4%) |
| Dec 2014 | $298.47 M(+118.6%) | $298.47 M(+48.3%) |
| Sep 2014 | - | $201.30 M(-10.0%) |
| Jun 2014 | - | $223.76 M(-8.4%) |
| Mar 2014 | - | $244.34 M(+79.0%) |
| Dec 2013 | $136.54 M(-811.4%) | $136.54 M(-9.6%) |
| Sep 2013 | - | $151.03 M(-1.2%) |
| Jun 2013 | - | $152.92 M(+348.7%) |
| Mar 2013 | - | $34.08 M(-277.5%) |
| Dec 2012 | -$19.19 M(-92.0%) | -$19.19 M |
| Dec 2011 | -$238.60 M | - |
FAQ
- What is PTC Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for PTC Therapeutics?
- What is PTC Therapeutics annual shareholders equity year-on-year change?
- What is PTC Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for PTC Therapeutics?
- What is PTC Therapeutics quarterly shareholders equity year-on-year change?
What is PTC Therapeutics annual stockholders equity?
The current annual shareholders equity of PTCT is -$818.55 M
What is the all time high annual shareholders equity for PTC Therapeutics?
PTC Therapeutics all-time high annual stockholders equity is $594.33 M
What is PTC Therapeutics annual shareholders equity year-on-year change?
Over the past year, PTCT annual stockholders equity has changed by -$471.47 M (-135.84%)
What is PTC Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PTCT is -$1.05 B
What is the all time high quarterly shareholders equity for PTC Therapeutics?
PTC Therapeutics all-time high quarterly stockholders equity is $663.65 M
What is PTC Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, PTCT quarterly stockholders equity has changed by -$383.54 M (-57.18%)